Johnson & Johnson (JNJ) Accumulated Expenses (2009 - 2026)

Johnson & Johnson has reported Accumulated Expenses for 18 years, with the latest figure at $9.5 billion in Q2 2026.

• Quarterly Accumulated Expenses rose 27.82% year-over-year to $9.5 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $9.5 billion (up 27.82% YoY) and the FY2025 annual result came in at $8.6 billion, up 0.53% from the prior year.
• Accumulated Expenses rose to $9.5 billion in Q2 2026 per JNJ's latest filing, from $7.4 billion in the prior quarter.
• Over five years, Accumulated Expenses peaked at $13.6 billion in Q1 2022 and troughed at $7.4 billion in Q1 2026.
• A 5-year average of $10.2 billion and a median of $10.3 billion in 2024 frame the typical range for Accumulated Expenses.
• The sharpest annual moves came in 2025 and 2026: Accumulated Expenses plunged 33.62% in 2025, then advanced 27.82% in 2026.
• Over 5 years, Accumulated Expenses stood at $12.0 billion in 2022, then fell by 14.57% to $10.2 billion in 2023, then fell by 16.28% to $8.5 billion in 2024, then increased by 0.53% to $8.6 billion in 2025, then gained by 10.12% to $9.5 billion in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $9.5 billion, $7.4 billion, and $8.6 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.